Dr. Roland Van Kimmenade and I discuss: Liberal Fluid Intake Versus Fluid Restriction In Chronic Heart Failure March 30, 2025 Disclosures: TBD
Dr. Sergio Raposeiras Roubin and I Discuss: Dapagliflozin In Patients Undergoing Transcatheter Aortic Valve Implantantion March 29, 2025 Disclosures: TBD Copyright NEJM
Dr. Antonius Buescher and I discuss: Development And External Validation Of A Deep Learning Electrocardiogram Model For Risk Stratification Of Coronary Revascularization Need In The Emergency Department March 29, 2025 Disclosures: TBD
Dr. Luke Laffin and I discuss: Efficacy Of Lorundrostat, A Novel Aldosterone Synthase Inhibitor, In Patients With Uncontrolled Hypertension On A Standardized Antihypertensive Medication Regimen March 29, 2025 Disclosures: TBD
Dr. Hyo-Soo Kim and I discussed the HOST-BR trial on optimal DAPT duration and thrombosis-bleeding balance in ACS patients. 3-month DAPT reduced thrombosis vs. 1-month in high bleeding risk, and reduced bleeding vs. 12-month in low-risk patients March 29, 2025 Disclosures: TBD
Dr. Keyvan Karkouti and I discussed the FARES-II trial. PCC is superior to FP for hemostasis in managing excessive bleeding among cardiac surgery ptS with coagulopathy. March 29, 2025 Disclosures: TBD
Dr. Marc Bonaca and I discussed the STRIDE trial. Semaglutide improves functional outcomes in DM pts with symptomatic PAD, addressing a critical unmet need. March 29, 2025 Disclosures: TBD
THIS WEEK IN OBESITY: Gibson and Dr. Perreault discuss the possibility or lack thereof that we can prevent and/or reverse diabetes and obesity. March 6, 2025
THIS WEEK IN OBESITY: Dr. Gibson and Dr. Perreault discuss the concept that there may or may not be an obesity set point throughout various stages of life. March 4, 2025
Dr. Gibson and Dr. Perreault discuss her PATHWEIGH study for pragmatic weight management in primary care. February 28, 2025
